Previous close | 1.5200 |
Open | 1.5400 |
Bid | 0.0000 x 900 |
Ask | 0.0000 x 1200 |
Day's range | 1.5000 - 1.6000 |
52-week range | 1.0400 - 3.2300 |
Volume | |
Avg. volume | 316,132 |
Market cap | 80.969M |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 28 Aug 1996 |
1y target est | N/A |
VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology.
VIENNA, Va., March 06, 2024--CEL-SCI Corporation issues letter to shareholders.
VIENNA, Va., February 15, 2024--CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results.